Mike Stocum | Bantam Pharmaceutical – Targeting Cancer Through the Mitochondria

from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search

In this episode of Executive Insights for Life Sciences Innovators, we speak with Mike Stocum of Bantam Pharmaceutical, a biotech developing therapies that target cancer cells through their mitochondria. Mike shares how Bantam is advancing its lead programs and building a strategy to translate cutting-edge science into new treatment options for patients.Learn more at ⁠genecoda.com⁠.Originally recorded and streamed on YouTube Live on September 19, 2025.

Episode metadata supplied by the publisher feed · Published Sep 22, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Mike Stocum | Bantam Pharmaceutical – Targeting Cancer Through the Mitochondria

0:00 34:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Executive Insights for Life Sciences Innovators?

This episode is 34 minutes long.

When was this Executive Insights for Life Sciences Innovators episode published?

This episode was published on September 22, 2025.

Can I download this Executive Insights for Life Sciences Innovators episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!